Building on several recent studies that have found massive overpayments to Medicare Advantage (MA) plans, the Center for Medicare Advocacy released a report outlining how policymakers can look to utilize cost savings by reining in overpayments to … [Read more...] about Improving Medicare by Reining in Medicare Advantage Overpayments: Policy Options
The Fight
More Medicare Prescription Drug Help for Beneficiaries in 2024 – Including Out-of-Pocket Cap
The Inflation Reduction Act of 2022 (IRA), signed into law by President Biden on August 16, 2023, is already providing cost-savings for Medicare beneficiaries in 2023, including a monthly cap of $35 for covered insulin and free vaccines for certain … [Read more...] about More Medicare Prescription Drug Help for Beneficiaries in 2024 – Including Out-of-Pocket Cap
New Research Outlines Extent of Medicare Advantage Overpayments: It’s Much Worse Than We Thought
On June 13, 2023, the USC Schaeffer Center for Health Policy & Economics published a white paper titled “Medicare Advantage Enrolls Lower-Spending People, Leading to Large Overpayments” by Steven M. Lieberman, Samuel Valdez, PhD and Paul … [Read more...] about New Research Outlines Extent of Medicare Advantage Overpayments: It’s Much Worse Than We Thought
President Biden’s Prescription for Medicare Solvency
Before rolling out his Administration’s proposed budget today, President Biden authored a New York Times guest essay titled “Joe Biden: My Plan to Extend Medicare for Another Generation” (March 7, 2023). The same day, the White House released a … [Read more...] about President Biden’s Prescription for Medicare Solvency
Center for Medicare Advocacy Weighs in on IRA Implementation
The Center for Medicare Advocacy was honored to participate in a recent meeting with leadership of the Department of Health & Human Services (HHS) and a group of Medicare advocacy organizations to discuss implementation of the Inflation Reduction … [Read more...] about Center for Medicare Advocacy Weighs in on IRA Implementation
Provisions of Recently Passed Medicare Drug Bill in Effect Next Month – January 2023
As discussed in a recent CMA Alert (Aug. 18, 2022), President Biden signed into law the Inflation Reduction Act (IRA) of 2022 on August 16, 2022. This bill includes historic prescription drug provisions that will soon be of significant benefit to … [Read more...] about Provisions of Recently Passed Medicare Drug Bill in Effect Next Month – January 2023
Senate Passes Historic Reconciliation Bill, House Vote Imminent
Bill Includes Critical Medicare and Affordable Care Act ProvisionsOn Sunday, August 7, 2022, the U.S. Senate passed the Inflation Reduction Act (IRA) of 2022, which includes expansive health and climate provisions. The House is scheduled to … [Read more...] about Senate Passes Historic Reconciliation Bill, House Vote Imminent
Senate Poised to Vote on Important Bill with Valuable Medicare Drug Provisions
The Senate is nearing a vote on the Inflation Reduction Act (IRA) of 2022, a scaled back, but still transformational, reconciliation package that includes critical Medicare prescription drug and Affordable Care Act (ACA) improvements.Among other … [Read more...] about Senate Poised to Vote on Important Bill with Valuable Medicare Drug Provisions
A Special Alert about Medicare’s Future | Don’t Let Traditional Medicare “Wither on the Vine*”
Recent CMA Alerts (for example, here) have discussed how policymakers fail to address the growing inequities between Medicare Advantage (MA) and traditional Medicare that favor MA, and encourage the growing privatization of the Medicare program. … [Read more...] about A Special Alert about Medicare’s Future | Don’t Let Traditional Medicare “Wither on the Vine*”
Senate Finance Committee Holds Hearing on Medicare Solvency
On February 2, 2022, the Senate Finance Committee’s Subcommittee on Fiscal Responsibility and Economic Growth held a hearing entitled “The Hospital Insurance Trust Fund and the Future of Medicare Financing” (for a link to a recording of the hearing, … [Read more...] about Senate Finance Committee Holds Hearing on Medicare Solvency